Implicit Bioscience Limited
Woolloongabba, AU· latest recorded location
Implicit Bioscience Limited is named on 2 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 2
- Published applications
- 4
- Inventors
- 5
- Granted in 2026 so far
- 1
- Most recent grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2022 | 0 | 2 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 6 documents
Recent patents
- Methods and agents for treating acute neuroinflammatory injury25 Aug 2026US 12,714,738 B2
- CD14 antagonist antibodies for treating neurodegenerative diseases13 May 2025US 12,297,287 B2
- Agents and methods for treating myopathies20 Aug 2026US 2026/0242502 A1
- Therapeutic methods and agents for the treatment of myocardial infarction4 Sep 2025US 2025/0276059 A1
- Methods and agents for treating acute neuroinflammatory injury11 Aug 2022US 2022/0249610 A1
- Cd14 antagonist antibodies for treating neurodegenerative diseases13 Jan 2022US 2022/0010025 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.